ACC.24 - A structured approach to treat hypercholesterolemia with an "inclisiran first" strategy in US patients with ASCVD performs much better than usual care, according to Michael Koren. He hopes that the results of VICTORION-INITIATE are a wake-up call to treat patients more aggressively with lipid-lowering therapies.
Early aggressive lipid-lowering strategy with PCSK9 siRNA performs better than usual care in US patients with ASCVD
Share
Save
Restart
Resume
Transcript
Early aggressive lipid-lowering strategy with PCSK9 siRNA performs better than usual care in US patients with ASCVD
closeShare this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Overview
Educational information
This video was recorded in response to a presentation at the Congress of the American College of Cardiology (ACC) 2024.
Faculty
Michael Koren, MD is is a practicing cardiologist and Chief Executive Officer at Jacksonville Center for Clinical Research , Jacksonville, FL, US.
Disclaimer
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Read our summary of the VICTORION-INITIATE trial
Release date: 7 april 2024
Recommended
Details
Presenters
Overview
ACC.24 - A structured approach to treat hypercholesterolemia with an "inclisiran first" strategy in US patients with ASCVD performs much better than usual care, according to Michael Koren. He hopes that the results of VICTORION-INITIATE are a wake-up call to treat patients more aggressively with lipid-lowering therapies.
Educational information
This video was recorded in response to a presentation at the Congress of the American College of Cardiology (ACC) 2024.
Faculty
Michael Koren, MD is is a practicing cardiologist and Chief Executive Officer at Jacksonville Center for Clinical Research , Jacksonville, FL, US.
Disclaimer
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Read our summary of the VICTORION-INITIATE trial
Release date: 7 april 2024
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?